@valefacc22

Medical Physicist at Fondazione IRCCS San Gerardo dei Tintori Monza (Italy)

 Monza, Lombardia
Joined July 2014
  • Tweets126
  • Following293
  • Followers295
20Media
Valeria Faccenda retweeted
Optimize RT@Optimize_RTOct 7
📢 Join the free OPTIMIZE-RT online course on CBCT optimisation in Radiotherapy! 🤝 Learn, collaborate and implement change in your department. 🔗docs.google.com/forms/d/e/1F… #OptimizeRT #Radiotherapy #EuropeanProject
1
1
7
Valeria Faccenda retweeted
Daniel E Spratt
@DrSpratticusSep 29
Across 3 prospective studies, the signal for post-prostatectomy SBRT in 5 fx is increasingly consistent: feasible, low toxicity & excellent in-field control. StereoBed randomized data show no PRO/toxicity penalty; POPART/esSBRT show few local failures. #ASTRO26 @rtdess @HimanshuNagarMD @RadOncDocJ @NRGonc @ASTRO_org @urotoday @ChadTangMD @TylerSbrt @SbrtSean @jryckman3 @seanmmcbride
2
33
1
72
4,273
Valeria Faccenda retweeted
Federica Ferrario@Fefe_FerrarioSep 29
So proud of our #POPART around the 🌍 superbly presented by @PanizzaDenis 👏🏼 @StAr_MCM74 @valefacc22 @CChissotti @CiroFranzese1 @Raffa_Lucchini @roberta_muni
Daniel E Spratt
@DrSpratticusSep 29
Post-prostatectomy RT in just 5 fractions? 👀 Ferrario et al and POPART team reports 100 pts treated with prostate-bed SBRT (32.5 Gy/5 fx): • Late ≥G2 GU toxicity: 8.5% • Only 1 late G2 GI event • Just 3 in-field relapses • 30-mo biochemical control: 74% Very encouraging local control and toxicity—but urinary QoL remains important to watch. #ASTRO26 #ProstateCancer #SBRT @HimanshuNagarMD @rtdess @RadOncDocJ @angela_jia_ @urotoday @TylerSbrt
4
6
25
1,448
Valeria Faccenda retweeted
Dr. Andrew Loblaw@DrAndrewLoblawSep 27
And PACE-POSTOP coming: (66/33 or 52.5/20) va 32.5/5 Should be open early 2027…
Lauren Henke, MD, MSCI@lauren_henkeSep 27
Replying to @lauren_henke
SO, the GU-003 data could continue to look worse with time as f/u matures, because of the DOSE ESCALATION. 📉 These data don’t kill hypofrac, they just strengthen the case for 52.5 Gy/20 fx, as used in RADICALS, to be preferred hypofrac postop regimen—shorter tx **without the dose escalation** used in GU003. #ASTRO26 #ProstateCancer   #ASTRO26 #Pcsm #RadOnc
1
6
35
2,730
Valeria Faccenda retweeted
Federica Ferrario@Fefe_FerrarioSep 15
🚨 New publication! 3-fx SBRT (30Gy) with real-time US tracking for localized #PCa: safe, well tolerated, low severe side effects, preserved QoL & encouraging early BRFS results (98.2% at 12mo) Huge congrats 👏🏼 @matteo_mom64240 & Ilenia on their 1️⃣paper! mdpi.com/2072-6694/18/18/295…
1
9
28
1,266
Valeria Faccenda retweeted
Filippo Alongi@alongi_filippoJul 22
“How to’ do SBRT in prostate cancer” consensus recommendations is to define minimum requirements, common practices and additional options for prostate SBRT based on scientific evidence, expert opinion and consensus. @RO_GreenJournal @ESTRO_RT Read it 👉 thegreenjournal.com/article/…
1
49
92
4,721
Valeria Faccenda retweeted
Dr. Andrew Loblaw@DrAndrewLoblawJun 20
Congrats on this work and publication @ZilliThomas ! Yours and @StAr_MCM74 show good tolerance with short to medium term FU. Maybe less hypoxia with SBRT will show that SBRT x1 is equally effective as SBRT x5. But need to do RCT. What would be your primary outcome?
Thomas Zilli@ZilliThomasJun 18
Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer jamanetwork.com/journals/jam… @Mat_Guc @CiroFranzese1 @alongi_filippo @Achard_Verane

Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer

This nonrandomized clinical trial evaluates the efficacy and tolerance of single-fraction stereotactic body radiotherapy in men with localized prostate cancer.

jamanetwork.com
2
3
14
4,409
Valeria Faccenda retweeted
Optimize RT@Optimize_RTJun 18
📢 SAVE THE DATE Optimisation of CBCT Imaging in Radiotherapy 🗓️ 16 October 2026 📍 Monza, Italy ✅ Free registration 🌍 Training in English for ROs, MPs & RTTs More details coming soon! #OptimizeRT #Radiotherapy #EuropeanProject
3
1
4
146
Valeria Faccenda retweeted
Thomas Zilli@ZilliThomasJun 18
Single-fraction SBRT for localized prostate cancer continues to push the boundaries. Multicenter phase 1/2 trial (45 pts), single 19-Gy fraction:
✅ 3-year bRFS: 92.9%
✅ Grade 2+ GU AE: <10%
✅ Grade 2+ GI AE: <5%
3
3
15
990
Valeria Faccenda retweeted
ESTRO@ESTRO_RTMay 29
⏳ Deadline 1 June! Help map CBCT imaging practices across Europe for the #OPTIMIZE-RT project. Calling all European #RTTs, #MedPhys, #Oncologists & #QualityManagers. 👉 Join here: bit.ly/4u9i9fT #Radiotherapy #Radonc #PatientSafety
2
5
398
Valeria Faccenda retweeted
Alison Tree 💙@alison_treeMay 17
Great debate @ESTRO_RT - do we need augmented/adaptive radiotherapy for prostate cancer? @CZamboglou @DrAndrewLoblaw @valefacc22 and Adam Mitchell @royalmarsdenNHS Good points made by both sides, but if we can do better, surely we should?
3
7
1
26
3,542
First ESTRO missed since Madrid 2021…a lot of FOMO, but I’ll still be there in thoughts and somehow also in face 😊 Don’t miss tomorrow debate on augmented SBRT for prostate cancer, which I was honored to contribute to 🌰 Can’t wait to follow the discussion! #ESTRO26 #PCa #GU
1
1
1
10
929
🧠 Fusion uncertainty is real...even “perfect” expert fusions can differ. Quantifying operator variability is key to define a probabilistic GS and benchmarking automatic registration vs human performance 🧮 @EFOMP_org @fisica_medica #SRS #automatism 👉🏻physicamedica.com/article/S1…
2
8
586
Valeria Faccenda retweeted
Stefano Arcangeli@StAr_MCM74Feb 16
🔍Check out a post-hoc analysis of the ABRUPT trial on the 🔗between ☢️ RT dose to pelvic substructures & late GU TOX ⛔️ bladder trigone D1cc ≥20.3 Gy ⛔️ NVB D0.035 cc ≥23.6 Gy ➡️doi.org/10.1016/j.ctro.2026.… #prostatecancer @OncoAlert @oncodaily @urotoday
2
7
17
1,376
Valeria Faccenda retweeted
Stefano Arcangeli@StAr_MCM74Feb 7
🙏 Huge credit to all speakers, moderators and colleagues who made the 1️⃣#prostateSBRTMonza 🇮🇹Symposium a great success🤩 #ProstateCancer @ESTRO_RT @ISRSy @airo_young
6
26
1,250
🚀 Join us for the 1st symposium on prostate SBRT. Medical physicists are welcome too! 📅 5–6 February 2026 📍 Hotel de la Ville, Monza 🔗 tinyurl.com/sbrt2026 Don’t miss this chance to learn and discuss with experts in the field. @ESTRO_RT @ISRSy @fisica_medica @AIRO
Federica Ferrario@Fefe_Ferrario28 Nov 2025
🧨 Join us for #PCa #SBRT Symposium by @StAr_MCM74 & @PanizzaDenis with 🔝tier international faculty @piet_ost @CDraulans @CZamboglou and 🌟Italian RadOncs together with @ESTRO_RT President @BarbaraJereczek 🔗Registrations open—limited seats tinyurl.com/sbrt2026 @valefacc22
1
6
1,404
AIRO 2025 couldn’t have been better! 🔹 Presented the #POPART data (again 🤭) 🔹 Elected Board Member & Secretary of the GU Study Group 🔹 Awarded the AIRO Young Scholarship for an ESTRO School Feeling grateful, inspired and ready for the next steps 🚀 #AIRO2025 #RadOnc
4
2
31
1,705
Valeria Faccenda retweeted
Stefano Arcangeli@StAr_MCM7423 Nov 2025
💥 #AIRO2025: 3 days of updates in cutting-edge treatments… yet the best one is still us❗️💪🏻 #radonc @unimib @AIROyoung
1
9
401
Valeria Faccenda retweeted
Shankar Siva
@_ShankarSiva29 Sep 2025
📢 NRGGU005 Phase III: 698 pts with intermediate-risk #ProstateCancer RCT; SBRT (n=353) vs M-IMRT (n=345) ✅ SBRT → better bowel HRQOL (MCID 35% vs 44%, p=0.03) ⚖️No diff in urinary HRQOL; EPIC continence favours SBRT ❌futile for DFS; IMRT had ⬇️3-yr biochemical failure (4.2% vs 7.8%) SBRT safe, better QoL, ⁉️but not superior for DFS #ASTRO25 #RadOnc #PCSM
4
23
1
52
8,337
Valeria Faccenda retweeted
Daniel E Spratt
@DrSpratticus28 Sep 2025
#astro25 @NRGonc Rtog 0924 trial on 2500 patients testing whole pelvic RT. Negative trial -OS no difference -PCSM no difference -DM no difference -BCR was not SS different with only 4% difference at 10 years. -toxicity increased 3 cooperative group trials now negative: getug01, Rtog 9413, Rtog 0924. Goodbye WPRT
16
67
8
182
50,420
Load more